Obesity
-
healthOrforglipron Pill Sustains Weight Loss After Injection Discontinuation
New trial shows oral GLP-1 orforglipron helps maintain weight loss after stopping injectable therapies tirzepatide and semaglutide.
-
healthNew Obesity Drug Outperforms Traditional Treatments in Early Trials
Experimental quintuple agonist shows promise in targeting obesity and diabetes by combining GLP-1, GIP, and PPAR activity.
-
health8,500 Steps, Not 10,000: New Study Reveals Weight Loss Sweet Spot
European researchers found walking 8,500 steps daily is optimal for weight loss and preventing regain, challenging the 10,000-step standard.
-
healthBreakfast Timing Slows Biological Aging, Study Finds
New research links time-restricted eating and breakfast timing to slower organ-specific biological aging in adults with obesity and metabolic issues.
-
healthSemaglutide Cuts Heavy Drinking in Alcohol Disorder Trial
A new trial shows semaglutide reduced heavy drinking in patients with alcohol use disorder and obesity, suggesting a new use for GLP-1 drugs.
-
health11 Cancers Rising in Younger Adults in England: Lifestyle Not the Full Story
A major study reveals 11 cancers are increasing in younger adults. Lifestyle factors don't fully explain the trend, pointing to urgent need for more research.
-
healthNew App Helps Obese Mothers Manage Pregnancy Weight Gain
A clinical trial shows a smartphone app, combined with standard care, effectively reduces excessive gestational weight gain in pregnant women with overweight or obesity.
-
healthEarly Weight Gain Decades Higher Mortality Risk, Major Study Finds
New research indicates that weight gain in one's 20s poses a significantly higher risk of early death compared to later-life weight gain.